Extended-Release vs Sublingual Buprenorphine in Pregnancy Through 12 Months Post Partum
A 13-site randomized clinical trial in JAMA Internal Medicine found weekly extended-release buprenorphine produced higher illicit opioid abstinence during pregnancy than sublingual buprenorphine, with fewer serious adverse events.
